Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Markets Raise Chances for a Fed Rate Hike Following Hot Inflation Report Nvidia Stock Drops PostEarnings Why Sellers May Be Overlooking the LongTerm Picture Q4 Earnings Season Peak 160 Companies Including RVNL Suzlon Energy NBCC and Container Corporation Set to Report on May 25 2026 Wall Street Rallies Dow Achieves Record High Amid Optimism Over Middle East Situation Standard Chartered to Cut Over 15 of Corporate Functions Roles in Efficiency Drive Direct Indexing Could Generate 19000 Annual Income on 700000 Portfolio C4 Therapeutics Q1 2026 Earnings EPS Surprises to the Upside as Biotech Focuses on Pipeline Execution MCHP Q1 2026 Earnings EPS Beats Estimates by 106 Stock Rises 255 SPME Q1 2026 Earnings EPS Misses Estimates by Nearly 20 as Preferred Shares Edge Lower STGW Q1 2026 Earnings Slight EPS Miss but Stock Rises 35 Catalyst Pharmaceuticals Inc CPRX Q1 2026 Earnings EPS Beats Estimates by 75 Stock Edges Slightly Lower AMETEK Inc AME Edges Higher as Technical Indicators Suggest RangeBound Trading Erasca Inc ERAS Surges 843 as Biotech Sector Momentum Accelerates MoneyHero MNY Holds Flat at 136 as Traders Eye Key Support and Resistance Levels Carlyle Group CG Rises 15 as Alternative Asset Manager Holds Key Support CII Holds Steady at 2479 as Price Action Remains RangeBound EML Q1 2026 Earnings Significant EPS Miss Despite Slight Stock Uptick SRFM Q1 2026 Earnings EPS Surprise Beats Estimates Amid PreRevenue Operations THRM Q1 2026 Earnings EPS Crushes Estimates with 625 Surprise SuRo Capital Corp SSSS Q1 2026 Earnings Massive EPS Surprise of 3727 as Reported Earnings Soar Above Negative Estimates Host Hotels Resorts HST Q1 2026 Earnings A Stellar EPS Beat Fuels Market Optimism Kalaris Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid PreRevenue Biotech